top of page

Recent Posts

FDA Grants Rare Pediatric Designation for Iopofosine-131 in Glioma Subset

OPACC
7 hours ago
1 min read

The FDA granted rare pediatric disease designation to iopofosine-131 for treating relapsed or refractory pediatric high-grade glioma.

Read more: https://www.curetoday.com/view/fda-grants-rare-pediatric-designation-for-iopofosine-131-in-glioma-subset

Comments

FDA Grants Rare Pediatric Designation for Iopofosine-131 in Glioma Subset

‘Switch’ could turn off growth of tough childhood cancer

Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing

Higher levels of HIF2α found to slow down aggressive childhood cancer

University of Minnesota study uncovers new genetic factors in childhood leukemia

Survivors of high-risk neuroblastoma face substantial late effects of modern therapies

Researchers develop a new approach for treating children with neuroblastoma

Pesticides used near farm communities tied to rare but deadly childhood cancer

Fruit fly study reveals genetic targets for rare childhood brain cancer treatment

Children’s Hospital Los Angeles Researchers Discover Possible Cell of Origin for Ewing Sarcoma

Archive

Search By Tags

bottom of page